Your browser doesn't support javascript.
loading
High negative predictive value of 68Ga PSMA PET-CT for local lymph node metastases in high risk primary prostate cancer with histopathological correlation.
Rahman, Labib Ataur; Rutagengwa, Damacent; Lin, Peter; Lin, Michael; Yap, June; Lai, Ken; Mancuso, Pascal; Rathore, Prem; Haghighi, Kayvan; Gassner, Paul; Wong, Lee Hao; Lalak, Nestor.
Afiliación
  • Rahman LA; Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, Australia. labib.rahman@health.nsw.gov.au.
  • Rutagengwa D; South Western Sydney Clinical School, University of New South Wales, Sydney, Australia. labib.rahman@health.nsw.gov.au.
  • Lin P; Department of Urology, Campbelltown Hospital, Sydney, Australia.
  • Lin M; School of Medicine, Western Sydney University, Sydney, Australia.
  • Yap J; Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, Australia.
  • Lai K; South Western Sydney Clinical School, University of New South Wales, Sydney, Australia.
  • Mancuso P; School of Medicine, Western Sydney University, Sydney, Australia.
  • Rathore P; Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, Australia.
  • Haghighi K; South Western Sydney Clinical School, University of New South Wales, Sydney, Australia.
  • Gassner P; School of Medicine, Western Sydney University, Sydney, Australia.
  • Wong LH; Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, Australia.
  • Lalak N; Department of Nuclear Medicine and PET, Liverpool Hospital, Sydney, Australia.
Cancer Imaging ; 19(1): 86, 2019 Dec 11.
Article en En | MEDLINE | ID: mdl-31829288
BACKGROUND: Current guidelines highlight the importance of accurate staging in the management and prognostication of high risk primary prostate cancer. Conventional radiologic imaging techniques are insufficient to reliably detect lymph node metastases in prostate cancer. Despite promising results, there is limited published data on the diagnostic accuracy of PSMA PET-CT to assess local nodal metastases prior to radical prostatectomy. This study aims to assess the diagnostic efficacy of 68Ga PSMA PET-CT in local lymph node staging of high risk primary prostate cancer when compared to histopathological findings following radical prostatectomy with pelvic lymph node dissection. METHODS: We retrospectively analysed consecutive patients with high risk primary prostate cancer referred by urologists for primary staging PSMA PET-CT using a 68Ga-labeled PSMA ligand, Glu-NH-CO-NHLys-(Ahx)-[HBEDD-CC], from October 2015 to October 2017. The scans of patients who underwent radical prostatectomy with pelvic lymph node dissection were interpreted by the consensus reading of two experienced nuclear medicine physicians blinded to clinical and histopathological data. The contemporaneous records of the referring urologists were retrospectively reviewed for noteworthy unexpected PET findings that altered their personal preference for surgical management. RESULTS: Seventy-one patients were recruited and analysed. PSMA PET-CT showed findings compatible with local disease in 47 patients (66.2%), lymph node metastases in 10 patients (14.1%) and distant metastases in 14 patients (19.7%). Twenty-eight patients (twenty-seven of whom had local disease only) underwent surgery yielding 214 lymph nodes, all of which were negative on histopathological analysis. On a node-based analysis, 213 of 214 lymph nodes were accurately identified as negative for disease with a negative predictive value of 100%. 11 patients had unexpected PET findings contemporaneously documented by urologists to alter their preference for surgical management. CONCLUSIONS: PSMA PET-CT appears to have a high negative predictive value for local lymph node metastases in high risk primary prostate cancer when compared to histopathological findings following radical prostatectomy with pelvic lymph node dissection.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Neoplasias de la Próstata / Glicoproteínas de Membrana / Radiofármacos / Tomografía Computarizada por Tomografía de Emisión de Positrones / Metástasis Linfática Tipo de estudio: Diagnostic_studies / Etiology_studies / Evaluation_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Cancer Imaging Asunto de la revista: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos Organometálicos / Neoplasias de la Próstata / Glicoproteínas de Membrana / Radiofármacos / Tomografía Computarizada por Tomografía de Emisión de Positrones / Metástasis Linfática Tipo de estudio: Diagnostic_studies / Etiology_studies / Evaluation_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Aged / Humans / Male / Middle aged Idioma: En Revista: Cancer Imaging Asunto de la revista: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Reino Unido